SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of the International Association of Physicians in AIDS Care (JIAPAC)
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Iregbu, K. C.
Right arrow Articles by Elegba, O. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iregbu, K. C.
Right arrow Articles by Elegba, O. Y.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Prevalence of Kaposi's Sarcoma Among Adult HIV-Seropositive Patients Seen in a Designated HIV Treatment and Care Center in Abuja, Nigeria

K. C. Iregbu, MBBS, MSc, MPH, FMCPath, FWACP

Department of Clinical Microbiology and Parasitology, National Hospital, P.M.B. 425 Garki, Abuja, Nigeria; keniregbu{at}yahoo.co.uk

O. Y. Elegba, MBBS, FMCPath

Department of Clinical Microbiology and Parasitology, National Hospital, Abuja, Nigeria.

Background: There is a dearth of information on the prevalence of AIDS-associated Kaposi's sarcoma (AAKS) in Nigeria despite the HIV National seroprevalence of 5% and the occurrence of the disease in people living with HIV/AIDS. Objective: To determine the prevalence of AAKS among HIV-seropositive adults seen in an HIV/AIDS treatment and care center in Abuja, Nigeria. Design: This was a retrospective study of all cases seen over a period of 42 months. Method: Medical records of the 1591 patients comprising 857 males and 734 females were reviewed, and relevant data such as age, sex, CD4 count at diagnosis of AAKS were obtained and analyzed.Results: A prevalence of 0.8% was found, with a male:female ratio of 2:1. Females presented at earlier ages and relatively lower CD4 count than did males. Conclusion: Easy access to antiretroviral medications and a well-targeted education and awareness campaign will help reduce the incidence and prevalence of the disease. The inability to perform histologic examinations on all suspected cases calls for a well-designed prospective study to determine the actual prevalence of Kaposi's sarcoma in HIV-seropositive patients in Nigeria.

Key Words: Kaposi's • sarcoma • prevalence • HIV-seropositive • Nigeria

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 5, No. 3, 115-118 (2006)
DOI: 10.1177/1545109706290176
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement